Alice M Deasy1, Ed Guccione1, Adam P Dale2, Nick Andrews3, Cariad M Evans1, Julia S Bennett4, Holly B Bratcher4, Martin C J Maiden4, Andrew R Gorringe5, Robert C Read2. 1. Department of Infection and Tropical Medicine, Sheffield Teaching Hospitals Foundation Trust. 2. Academic Unit of Clinical and Experimental Sciences and Institute for Life Sciences, University of Southampton, and NIHR Respiratory Biomedical Research Unit, University Hospital Southampton. 3. Statistics, Modeling and Economics Department, Health Protection Directorate, Public Health England, London. 4. Department of Zoology, University of Oxford. 5. Public Health England, Porton Down, Salisbury, United Kingdom.
Abstract
BACKGROUND: Herd protection by meningococcal vaccines is conferred by population-level reduction of meningococcal nasopharyngeal colonization. Given the inverse epidemiological association between colonization by commensal Neisseria lactamica and meningococcal disease, we investigated whether controlled infection of human volunteers with N. lactamica prevents colonization by Neisseria meningitidis. METHODS: In a block-randomized human challenge study, 310 university students were inoculated with 10(4) colony-forming units of N. lactamica or were sham-inoculated, and carriage was monitored for 26 weeks, after which all participants were reinoculated with N. lactamica and resampled 2 weeks later. RESULTS: At baseline, natural N. meningitidis carriage in the control group was 22.4% (36/161), which increased to 33.6% (48/143) by week 26. Two weeks after inoculation of N. lactamica, 33.6% (48/143) of the challenge group became colonized with N. lactamica. In this group, meningococcal carriage reduced from 24.2% (36/149) at inoculation to 14.7% (21/143) 2 weeks after inoculation (-9.5%; P = .006). The inhibition of meningococcal carriage was only observed in carriers of N. lactamica, was due both to displacement of existing meningococci and to inhibition of new acquisition, and persisted over at least 16 weeks. Crossover inoculation of controls with N. lactamica replicated the result. Genome sequencing showed that inhibition affected multiple meningococcal sequence types. CONCLUSIONS: The inhibition of meningococcal carriage by N. lactamica is even more potent than after glycoconjugate meningococcal vaccination. Neisseria lactamica or its components could be a novel bacterial medicine to suppress meningococcal outbreaks. This observation explains the epidemiological observation of natural immunity conferred by carriage of N. lactamica. CLINICAL TRIALS REGISTRATION: NCT02249598.
RCT Entities:
BACKGROUND: Herd protection by meningococcal vaccines is conferred by population-level reduction of meningococcal nasopharyngeal colonization. Given the inverse epidemiological association between colonization by commensal Neisseria lactamica and meningococcal disease, we investigated whether controlled infection of human volunteers with N. lactamica prevents colonization by Neisseria meningitidis. METHODS: In a block-randomized human challenge study, 310 university students were inoculated with 10(4) colony-forming units of N. lactamica or were sham-inoculated, and carriage was monitored for 26 weeks, after which all participants were reinoculated with N. lactamica and resampled 2 weeks later. RESULTS: At baseline, natural N. meningitidis carriage in the control group was 22.4% (36/161), which increased to 33.6% (48/143) by week 26. Two weeks after inoculation of N. lactamica, 33.6% (48/143) of the challenge group became colonized with N. lactamica. In this group, meningococcal carriage reduced from 24.2% (36/149) at inoculation to 14.7% (21/143) 2 weeks after inoculation (-9.5%; P = .006). The inhibition of meningococcal carriage was only observed in carriers of N. lactamica, was due both to displacement of existing meningococci and to inhibition of new acquisition, and persisted over at least 16 weeks. Crossover inoculation of controls with N. lactamica replicated the result. Genome sequencing showed that inhibition affected multiple meningococcal sequence types. CONCLUSIONS: The inhibition of meningococcal carriage by N. lactamica is even more potent than after glycoconjugate meningococcal vaccination. Neisseria lactamica or its components could be a novel bacterial medicine to suppress meningococcal outbreaks. This observation explains the epidemiological observation of natural immunity conferred by carriage of N. lactamica. CLINICAL TRIALS REGISTRATION: NCT02249598.
Authors: Won Jong Kim; Dustin Higashi; Maira Goytia; Maria A Rendón; Michelle Pilligua-Lucas; Matthew Bronnimann; Jeanine A McLean; Joseph Duncan; David Trees; Ann E Jerse; Magdalene So Journal: Cell Host Microbe Date: 2019-08-01 Impact factor: 21.023
Authors: Neil J Oldfield; Luke R Green; Julian Parkhill; Christopher D Bayliss; David P J Turner Journal: J Infect Dis Date: 2018-01-30 Impact factor: 5.226
Authors: Kanny Diallo; Caroline Trotter; Youssouf Timbine; Boubou Tamboura; Samba O Sow; Bassira Issaka; Ibrahim D Dano; Jean-Marc Collard; Marietou Dieng; Aldiouma Diallo; Adane Mihret; Oumer A Ali; Abraham Aseffa; Stephen L Quaye; Akalifa Bugri; Isaac Osei; Kadidja Gamougam; Lodoum Mbainadji; Doumagoum M Daugla; Galadima Gadzama; Zailani B Sambo; Babatunji A Omotara; Julia S Bennett; Lisa S Rebbetts; Eleanor R Watkins; Maria Nascimento; Arouna Woukeu; Olivier Manigart; Ray Borrow; James M Stuart; Brian M Greenwood; Martin C J Maiden Journal: J Infect Date: 2016-03-23 Impact factor: 6.072
Authors: Guro K Bårnes; Paul A Kristiansen; Demissew Beyene; Bereket Workalemahu; Paulos Fissiha; Behailu Merdekios; Jon Bohlin; Marie-Pierre Préziosi; Abraham Aseffa; Dominique A Caugant Journal: BMC Infect Dis Date: 2016-11-04 Impact factor: 3.090
Authors: Mirka E Wörmann; Corey L Horien; Errin Johnson; Guangyu Liu; Ellen Aho; Christoph M Tang; Rachel M Exley Journal: Microbiology (Reading) Date: 2016-01-26 Impact factor: 2.777
Authors: Rafael Custodio; Rhian M Ford; Cara J Ellison; Guangyu Liu; Gerda Mickute; Christoph M Tang; Rachel M Exley Journal: Elife Date: 2021-07-07 Impact factor: 8.140